Last Price | 29.42 | Max Price | 43.77 |
Min Price | 29.42 | 1 Year return | -42.28 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Annual report 2017 |
Contact info:Street: One Baxter ParkwayZip Code: 600154625City: DeerfieldCountry: USAPhone: (224) 9482000Website: www.baxer.comCEO: Robert L. ParkinsonCFO: Robert J. Hombach
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 11,362 | 2,019,579 | 0.56 % |
2020 | 11,673 | 2,170,517 | 0.54 % |
2021 | 12,784 | 2,404,876 | 0.53 % |
2022 | 15,113 | 2,645,792 | 0.57 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
Baxter in advanced talks to acquire Hill-Rom for about $10 billion
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Over the past year the company' stock gained around 20 percent. Over the period 2011-2016 the stock lost a modest -10,53 percent. Baxter International's revenues between 2011 and 2015 were very fluctuating and moved between 14,19 billion dollars and 9,97 billion dollars. Baxter International's net results between 2011 and 2015 were far from constant and moved between 2,26 billion dollars and 393 million dollars.
Baxter International has located her head office Deerfield. Baxter International's core business is the pharmaceutical sector. Robert L. Parkinson is leading the company as CEO. The CFO of the company is Robert J. Hombach. The past 10 years the (international) industry gained at around 75 percent. Since 2011 the sector is 147 percent higher and over the past year minus 75 percent.
Baxter International paid out dividends in the past 5 years. On average the Baxter International stock yielded a delivered a dividend yield of around 8,08 percent over the past 5 years. In the period 2011 till 2015 Baxter International paid it's investors each year a higher dividend per share. So because of the yearly raised dividends per share Baxter International is a kind of dividend aristocrat.
At the end of 2015 the pharmaceutical company's balance sheet was worth 20,98 billion dollars. The total debt of the pharmaceutical company was at the end of 2015 12,13 billion dollars, which equals around 57,83 percent of the total balance sheet. As per the end of 2015 Baxter International's price/earnings-ratio equaled 40. So investors paid for 1 stock 40 times the earnings per share of 2015. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 20,48 billion dollars. At the end of 2015 the American company had around 547,66 million stocks listed.
At this page you find all Baxter International's financial reports. More information about Baxter International can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
9,968
|
10,163
|
10,561
|
11,127
|
11,362
|
11,673
|
Costs |
9,000
|
5,198
|
9,959
|
9,581
|
10,361
|
10,571
|
Profit |
968
|
4,965
|
602
|
1,546
|
1,001
|
1,102
|
Margin of profit |
9.71
|
48.85
|
5.70
|
13.89
|
8.81
|
9.44
|
ROI |
10.94
|
59.89
|
6.60
|
19.71
|
12.70
|
12.68
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
8,846
|
8,290
|
9,124
|
7,844
|
7,882
|
8,689
|
Debt |
12,116
|
7,256
|
7,987
|
7,876
|
10,311
|
11,330
|
Total assets |
20,962
|
15,546
|
17,111
|
15,720
|
18,193
|
20,019
|
Solvency |
42.20
|
53.33
|
53.32
|
49.90
|
43.32
|
43.40
|
Cash |
7,361
|
2,801
|
3,394
|
1,838
|
3,335
|
3,730
|
Cashflow |
1,771
|
1,654
|
1,714
|
2,017
|
2,104
|
1,868
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.15
|
0.23
|
0.21
|
0.26
|
0.20
|
0.16
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
38.15
|
44.34
|
64.64
|
65.82
|
83.62
|
Eps |
9.01
|
1.08
|
2.83
|
1.93
|
2.13
|
Price/earnings-ratio |
4.23
|
41.06
|
22.84
|
34.10
|
13.81
|
Dividend |
0.51
|
0.61
|
0.73
|
0.85
|
0.96
|
Dividend % |
1.34 %
|
1.38 %
|
1.13 %
|
1.29 %
|
3.26 %
|
Payout % |
0.06
|
0.56
|
0.26
|
0.44
|
0.45
|
Book value |
15.36
|
16.85
|
15.29
|
15.57
|
17.21
|
Market to book |
0.40
|
0.38
|
0.24
|
0.24
|
0.58
|
Cashflow per stock |
3.07
|
3.17
|
3.93
|
4.16
|
3.70
|
Stocks |
540
|
541
|
513
|
506
|
505
|
Market Cap |
20.585.93
|
24.009.11
|
33.160.26
|
33.315.12
|
14.854.60
|
Date
|
Price
|
---|---|
17 Dec 2024
|
29.42
|
10 Dec 2024
|
31.85
|
06 Dec 2024
|
31.90
|
03 Dec 2024
|
33.55
|
29 Nov 2024
|
33.31
|
27 Nov 2024
|
32.87
|
13 Nov 2024
|
33.83
|
08 Nov 2024
|
36.04
|
05 Nov 2024
|
35.80
|
31 Oct 2024
|
35.86
|
29 Oct 2024
|
36.01
|
23 Oct 2024
|
36.59
|
19 Oct 2024
|
36.86
|
16 Oct 2024
|
36.65
|
14 Oct 2024
|
36.54
|
05 Oct 2024
|
36.32
|
02 Oct 2024
|
36.91
|
27 Sep 2024
|
38.71
|
20 Sep 2024
|
38.76
|
17 Sep 2024
|
40.26
|
13 Sep 2024
|
39.38
|
28 Aug 2024
|
37.91
|
26 Aug 2024
|
37.54
|
23 Aug 2024
|
36.49
|
11 Aug 2024
|
37.15
|
07 Aug 2024
|
36.59
|
05 Aug 2024
|
35.27
|
01 Aug 2024
|
35.82
|
30 Jul 2024
|
36.02
|
26 Jul 2024
|
35.09
|